egta acetoxymethyl ester has been researched along with picrotoxin in 1 studies
| Studies (egta acetoxymethyl ester) | Trials (egta acetoxymethyl ester) | Recent Studies (post-2010) (egta acetoxymethyl ester) | Studies (picrotoxin) | Trials (picrotoxin) | Recent Studies (post-2010) (picrotoxin) |
|---|---|---|---|---|---|
| 69 | 0 | 11 | 4,135 | 6 | 406 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, WP; Südhof, TC | 1 |
1 other study(ies) available for egta acetoxymethyl ester and picrotoxin
| Article | Year |
|---|---|
SV2 renders primed synaptic vesicles competent for Ca2+ -induced exocytosis.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Action Potentials; Analysis of Variance; Animals; Animals, Newborn; Calcium; Cells, Cultured; Cerebral Cortex; Egtazic Acid; Electric Stimulation; Excitatory Amino Acid Antagonists; Exocytosis; GABA Antagonists; Glycosylation; Green Fluorescent Proteins; Ionomycin; Ionophores; Lysine; Membrane Glycoproteins; Mice; Mice, Knockout; Models, Molecular; Mutation; Nerve Tissue Proteins; Neurons; Picrotoxin; Synaptic Transmission; Synaptic Vesicles; Synaptotagmins | 2009 |